Growth Metrics

Sarepta Therapeutics (SRPT) Net Margin (2012 - 2026)

Sarepta Therapeutics' quarterly Net Margin came in at 87.65% in Q1 2026, up 42328.0% year-on-year from N/an in Q1 2025, and up 237.26% quarter-over-quarter from 63.86% in Q4 2025.

Sarepta Therapeutics has reported Net Margin for 13 years, with the latest figure at 87.65% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 42328.0% year-over-year to 87.65%; the trailing twelve-month figure through Mar 2026 stood at 4.82% (up 1911.0% YoY), and the FY2025 full-year result was 32.45%, down 4572.0% from the prior year.
  • Net Margin for Q1 2026 stood at 87.65%, up from 63.86% in the prior quarter.
  • The five-year high for Net Margin was 194.66% in Q4 2022, with the low at 477.28% in Q1 2022.
  • Average Net Margin over 5 years is 65.27%, with a median of 12.34% recorded in 2023.
  • Year-over-year, Net Margin plunged 36345 bps in 2022 and soared 42328 bps in 2026.
  • Tracing SRPT's Net Margin over 5 years: stood at 194.66% in 2022, then plunged by 95 bps to 9.85% in 2023, then soared by 170 bps to 26.56% in 2024, then slumped by 340 bps to 63.86% in 2025, then soared by 237 bps to 87.65% in 2026.
  • The last three Net Margin figures came in at 87.65% (Q1 2026), 63.86% (Q4 2025), and 45.06% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 87.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 87.65%
Dec 31, 2025 -63.86%
Sep 30, 2025 -45.06%
Jun 30, 2025 32.92%
Mar 31, 2025 -335.63%
Dec 31, 2024 26.56%
Sep 30, 2024 7.28%
Jun 30, 2024 1.87%
Mar 31, 2024 8.84%
Dec 31, 2023 9.85%
Sep 30, 2023 -12.34%
Jun 30, 2023 -107.60%
Mar 31, 2023 -203.85%
Dec 31, 2022 194.66%
Sep 30, 2022 -124.05%
Jun 30, 2022 -109.60%
Mar 31, 2022 -477.28%
Dec 31, 2021 -66.40%
Sep 30, 2021 -25.42%
Jun 30, 2021 -57.39%
Mar 31, 2021 -113.83%
Dec 31, 2020 -841.63%
Sep 30, 2020 -873.52%
Jun 30, 2020 -579.65%
Mar 31, 2020 -132.25%
Dec 31, 2019 -235.44%
Sep 30, 2019 -127.55%
Jun 30, 2019 -291.97%
Mar 31, 2019 -88.08%
Dec 31, 2018 -166.91%
Sep 30, 2018 -97.33%
Jun 30, 2018 -148.60%
Mar 31, 2018 -54.74%
Dec 31, 2017 -41.90%
Sep 30, 2017 -103.87%
Jun 30, 2017 -180.07%
Mar 31, 2017 514.56%
Dec 31, 2014 -165,637.04%
Sep 30, 2014 -3,179.89%
Jun 30, 2014 -1,171.93%
Mar 31, 2014 -412.63%
Dec 31, 2013 -1,250.91%
Sep 30, 2013 -596.69%
Jun 30, 2013 -579.67%
Mar 31, 2013 -339.25%
Dec 31, 2012 -140.17%
Sep 30, 2012 -90.28%
Jun 30, 2012 -48.63%
Mar 31, 2012 -60.45%